Evidence map›Paper›PMID 33666789›Full record

ArticleEuropean journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology2021

The use of multi-pronged screening strategy to understand the epidemiology of carbapenemase-producing Enterobacteriaceae in Hong Kong: transition from epidemic to endemic setting.

Shuk- Ching Wong, Veronica Wing- Man Chan, Germaine Kit-Ming Lam, Christine Ho-Yan AuYeung, Elaine Yin-Ling Leung, Simon Yung-Chun So, Jonathan Hon-Kwan Chen, Siddharth Sridhar, Anthony Raymond Tam, Ivan Fan-Ngai Hung and 3 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. The Emergence ofInfection and drug resistance · 2024
    Article
  3. Article
  4. Gastrointestinal Colonization of Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  5. Control of Healthcare-Associated Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Shuk- Ching WongInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Veronica Wing- Man ChanInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Germaine Kit-Ming LamInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Christine Ho-Yan AuYeungInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Elaine Yin-Ling LeungInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Simon Yung-Chun SoDepartment of Microbiology, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Jonathan Hon-Kwan ChenDepartment of Microbiology, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China.
Siddharth SridharDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China.
Anthony Raymond TamDepartment of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China.
Ivan Fan-Ngai HungDepartment of Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China.
Pak- Leung HoDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China.
Kwok- Yung YuenDepartment of Microbiology, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong Special Administrative Region, China. kyyuen@hku.hk.
Vincent Chi-Chung ChengInfection Control Team, Queen Mary Hospital, Hong Kong, Hong Kong Special Administrative Region, China. vcccheng@hku.hk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A multi-pronged carbapenemase-producing Enterobacteriaceae (CPE) screening strategy was implemented in Hong Kong West healthcare network. Of 199,192 fecal specimens from 77,194 patients screening from 1 July 2011 to 30 June 2019, the incidence of CPE per 1000 patient admission significantly increased from 0.01 (2012) to 1.9 (2018) (p<0.01). With appropriate infection control measures, the incidence of nosocomial CPE per 1000 CPE colonization day decreased from 22.34 (2014) to 10.65 (2018) (p=0.0094). Exposure to wet market for purchasing raw pork (p=0.007), beef (p=0.017), chicken (p=0.026), and vegetable (p=0.034) for >3 times per week significantly associated with community acquisition of CPE. Strategic CPE control measures should be implemented in both the hospital and the community.

Indexed as

AdolescentAdultAgedAged, 80 and overAnimalsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeChildChild, PreschoolDiagnostic Screening ProgramsEndemic DiseasesEnterobacteriaceae InfectionsEpidemicsFecesFemaleBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemase-producing EnterobacteriaceaeEndemicityGastrointestinal colonization

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.